Shares of Edwards Lifesciences (NYSE:EW) got a little boost on Wall Street after the company posted a 67% spike in Sapien sales during its 1st quarter.
The Irvine, Calif.-based med-tech titan posted $459.2 million in sales during the 3 months ended March 31, a 13.5% increase from he $404.5 million in revenues posted during the same period last year.